loading

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
14.40%
4.3779
5.1146 3.115 3.4452 2.903
Income/Loss From Continuing Operations Before Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Income/Loss From Continuing Operations After Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Net Income/Loss
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Diluted Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Basic Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Diluted Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):